Lung Cancer Intratumoral Chemotherapy
Learn More About Intratumoral Chemotherapy for Lung Cancer: Chat with Us | Email Us
Intratumoral Chemotherapy for Lung Cancer
Intratumoral chemotherapy is an innovative non-small cell lung cancer treatment we are pioneering at Cancer Treatment Centers of America (CTCA) at Southwestern Regional Medical Center (Southwestern).
In 2005, Dr. Daniel Nader, DO, FCCP, our National Clinical Director of Pulmonary/Critical Care, began a research study to improve the quality of life for lung cancer patients with airway blockage problems. His ongoing study looks at the effectiveness of Cisplatin, a chemotherapy drug, when injected directly into a lung tumor, then followed by HDR brachytherapy.
During intratumoral chemotherapy treatment, Dr. Nader uses a bronchoscope to locate the tumor and then places a radiation catheter on the tumor site. He injects Cisplatin chemotherapy through the bronchoscope and into the tumor, followed by HDR brachytherapy to target cancer cells.
This research study has had some promising initial results. For more information about Dr. Nader's intratumoral chemotherapy study, please contact the Research Coordinator JJ Hale at 918-286-5449.
Next Topic: Radiation Therapy for Lung Cancer
